ABVC
ABVC Biopharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.75M
P/E Ratio
—
EPS
$-0.30
Beta
0.51
52W High
$3.07
52W Low
$0.71
50-Day MA
$0.98
200-Day MA
$1.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ABVC Biopharma Inc
American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States.
Fundamentals
| Revenue (TTM) | 797,920 |
| Gross Profit (TTM) | 797,920 |
| EBITDA | $-6.49M |
| Operating Margin | 0.00% |
| Return on Equity | -69.90% |
| Return on Assets | -22.90% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.40 |
| Price-to-Book | 2.95 |
| Price-to-Sales (TTM) | 111.69 |
| EV/Revenue | 184.61 |
| EV/EBITDA | -1.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 104.50% |
| Shares Outstanding | $26.69M |
| Float | $21.10M |
| % Insiders | 18.09% |
| % Institutions | 4.08% |
Historical Volatility
HV 10-Day
58.54%
HV 20-Day
53.52%
HV 30-Day
67.59%
HV 60-Day
84.97%
HV Rank
25.8%
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ABVC and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026